Skip to main content
. 2022 Aug 2;88(3):1061–1074. doi: 10.3233/JAD-220361

Fig. 2.

Fig. 2

Overview of Primary and Secondary Analysis Designs. AD, Alzheimer disease; ATT, average treatment effect in the treated; ICD, International Classification of Diseases; PSM, propensity score matching. aVaccinations were not considered if preceded by a diagnosis code or medication record for AD. bThe results of Step 6 are shown in Table 3.